The main purpose of the Medway Metabonomics Research Group (MMRG) is to develop and strengthen metabonomics and pharmacometabonomics capabilities in this region, with a special focus on the delivery of personalised and predictive medicine.

The analytical facilities available to this group include four nuclear magnetic resonance spectrometers (1 x 500MHz, 2 x 400MHz and 1 x 300 MHz) and 10 mass spectrometers (2 x LC-MS, 2 x LC-MSMS, 2 x GC-MS, 1 x LC-Qtof –MSMS, 2 x LC-ion mobility Qtof MSMS and 1 x MALDI). In addition, we use advanced computational and statistical methodologies to help analyse the metabonomics data.